ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02050529
Recruitment Status : Completed
First Posted : January 30, 2014
Last Update Posted : October 26, 2018
Sponsor:
Information provided by (Responsible Party):
Saima Aziz Siddiqui, Dow University of Health Sciences

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2014
  Actual Study Completion Date : March 2015